Moolec Science SA (MLEC)
1.68
-0.19
(-10.16%)
USD |
NASDAQ |
Oct 16, 16:00
1.57
-0.11
(-6.55%)
After-Hours: 20:00
Moolec Science Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -54.35% |
| September 30, 2024 | -29.83% |
| June 30, 2024 | -23.51% |
| March 31, 2024 | -13.14% |
| Date | Value |
|---|---|
| December 31, 2023 | -3.61% |
| September 30, 2023 | 10.76% |
| June 30, 2023 | -15.83% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Arcadia Biosciences, Inc. | 43.73% |
| Zivo Bioscience, Inc. | -- |
| PMGC Holdings, Inc. | 8.00% |
| TFA Therapeutics, Inc. | -- |
| Archer-Daniels-Midland Co. | 6.27% |